Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.
- NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_assertion description "[We document robust FoxO activation in Tsc1-deficient benign polycystic kidneys and FoxO extinction on progression to murine renal tumors; murine renal tumor progression on genetic deletion of both Tsc1 and FoxOs; and downregulated FoxO expression in most human renal clear cell and papillary carcinomas, yet continued expression in less aggressive RCCs and benign renal tumor subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.
- NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_assertion evidence source_evidence_literature NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.
- NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_assertion SIO_000772 21075312 NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.
- NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_assertion wasDerivedFrom befree-20150227 NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.
- NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_assertion wasGeneratedBy ECO_0000203 NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.
- befree-20150227 importedOn "2015-02-27" NP759522.RA_niRRhNpB5e6gnKm41XCcMvKGF2v6HOoWn2qiNzMN6s130_provenance.